UnitedHealth Group Incorporated stock (US91324P1021): Morgan Stanley lifts price target as valuation metrics come into focus

UnitedHealth Group Incorporated shares were steady on the NYSE on 06/04/2026 as Morgan Stanley raised its price target to USD 453, while investors assess current valuation multiples for the U.S. health insurer.

UnitedHealth Group Incorporated shares traded relatively calmly on the New York Stock Exchange on 06/04/2026, even as fresh analyst commentary refocused attention on the U.S. health insurer’s valuation.

According to the NYSE quote overview for ticker UNH, the stock last changed hands at around USD 398 on 06/04/2026, leaving the company firmly anchored in the United States market via its primary New York listing, with trading in U.S. dollars and inclusion in major U.S. equity indices.NYSE as of 06/04/2026

On the same day, Morgan Stanley updated its view on UnitedHealth Group Incorporated and lifted its 12?month price target to USD 453 from USD 395 while reiterating an overweight rating, according to an analyst note summarized by MarketBeat on 06/04/2026.MarketBeat as of 06/04/2026

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: UnitedHealth Group
• Sector/industry: Managed health care and health insurance
• Headquarters/country: Minnetonka, United States
• Core markets: United States with selected international operations
• Key revenue drivers: Health insurance premiums, Medicare and Medicaid plans, pharmacy and health services
• Home exchange/listing venue: New York Stock Exchange (UNH)
• Trading currency: USD

UnitedHealth Group Incorporated: core business model

UnitedHealth Group combines a large U.S.-focused health insurance franchise with technology-enabled health services, generating most of its revenue from premiums for medical coverage and related care management and pharmacy benefit offerings.

Valuation metrics and multiples for UnitedHealth Group Incorporated

With the stock trading near USD 398 on the NYSE on 06/04/2026, investors are closely watching how UnitedHealth Group Incorporated is valued relative to its earnings and cash flow.MarketWatch as of 06/04/2026

Based on trailing 12?month results reported in the company’s latest filings with the U.S. Securities and Exchange Commission for the period through 03/31/2026, the current share price implies a price-to-earnings ratio in the mid?teens and a dividend yield of around 1 percent, figures that position the health insurer within the typical valuation corridor for large-cap U.S. managed care companies.SEC Form 10-Q filed 04/16/2026

In that Form 10?Q for the quarter ended 03/31/2026, UnitedHealth Group reported consolidated revenue of approximately USD 108 billion and net earnings attributable to shareholders of just over USD 6 billion for the first three months of 2026, underlining the scale of the business and the earnings base on which these valuation ratios are calculated.UnitedHealth Group press release dated 04/16/2026

On a forward-looking basis, consensus estimates compiled across Wall Street for the next 12 months continue to frame UnitedHealth Group as a mature, cash-generative health insurer, and the updated Morgan Stanley target of USD 453 on 06/04/2026 highlights how at least some U.S. research houses see scope for upside relative to the current share price level.MarketBeat as of 06/04/2026

Conclusion

The combination of a relatively stable share price around USD 398 on the NYSE on 06/04/2026 and a higher Morgan Stanley price target of USD 453 has put a spotlight on how the market currently values UnitedHealth Group Incorporated’s large U.S. health insurance and services platform.

Against the backdrop of first-quarter 2026 revenue of about USD 108 billion and net earnings north of USD 6 billion reported on 04/16/2026, investors weighing the updated analyst assumptions are likely to focus on whether moderate valuation multiples appropriately capture both the scale of the business and the sector’s ongoing policy and cost trends.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.